Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 293 of 1,261
  1. US 11203754

    Microrna compositions and methods of making and using same

    Advanced ReGen Medical Technologies, LLC · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  2. US 11203583

    Prodrug and profluorescent compounds for selective mitochondrial imaging and therapeutic targeting

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  3. US 11203596

    Analogs of 3-amino-4-(propan-2-ylidene)cyclopentane-1-carboxylic acid and uses thereof for treating diseases and disorders associated with ornithine aminotransferase activity

    Northwestern University · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  4. US 11203582

    Benzamide derivatives for inhibiting endoplasmic reticulum (ER) stress

    The Board of Regents of the University of Oklahoma · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  5. US 11203581

    Highly purified pharmaceutical grade tasimelteon

    VANDA PHARMACEUTICALS INC. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  6. US 11203574

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  7. US 11203572

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  8. US 11203571

    Sulfonamides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  9. US 11202824

    Peptide fragments from filoviruses and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  10. US 11202823

    Multi-subunit vaccines to elicit both MHC- and CD1-restricted T cell responses

    Northwestern University · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  11. US 11202822

    Methods for treating hypophosphatemic disorders

    Ultragenyx Pharmaceutical Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  12. US 11202808

    Methods for treating autism spectrum disorder and associated symptoms

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  13. US 11202803

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  14. US 11202802

    Materials and methods for engineering cells and uses thereof in immuno-oncology

    CRISPR THERAPEUTICS AG · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  15. US 11202789

    Method of treating glycogen storage disease

    Viking Therapeutics, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  16. US 11202801

    Notch receptors with hinge domain

    The Regents of the University of California, UCSF · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  17. US 11203756

    Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, and methods of use

    Arrowhead Pharmaceuticals, Inc. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  18. US 11202776

    Treatment of gastroparesis with triazaspiro[4.5]decanone

    Takeda Pharmaceutical Company Limited · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  19. US 11202770

    Liquid tasimelteon formulations and methods of use thereof

    VANDA PHARMACEUTICALS INC. · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  20. US 11202825

    Attenuated infectious bronchitis virus

    The Pirbright Institute · Granted Dec 21, 2021 · Expires Dec 16, 2041

    granted
  21. US 2021387969

    BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS

    HEPTARES THERAPEUTICS LTD [GB] · Granted Dec 16, 2021 · Expires Dec 11, 2041

    granted
  22. US 11202152

    Acoustic beamforming

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  23. US 11197822

    Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted
  24. US 11198694

    HDAC6 inhibitors, with improved solubility and their uses

    Universität Regensburg · Granted Dec 14, 2021 · Expires Dec 9, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.